BioCentury
ARTICLE | Company News

University of California, Batu Biologics deal

November 3, 2014 8:00 AM UTC

University of California, San Diego granted exclusive, worldwide rights to Batu to develop and commercialize 10 peptide families that the company said stimulate cancer-killing immune responses. Batu s...